Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-2,064
Closed -$294K – 992
2023
Q4
$294K Sell
2,064
-118
-5% -$15.7K ﹤0.01% 861
2023
Q3
$286K Buy
2,182
+67
+3% +$10.2K ﹤0.01% 897
2023
Q2
$336K Buy
2,115
+15
+0.7% +$2.42K ﹤0.01% 765
2023
Q1
$332K Buy
+2,100
New +$315K ﹤0.01% 743
2022
Q3
– Sell
-11,833
Closed -$1.67M – 1087
2022
Q2
$1.67M Buy
+11,833
New +$1.69M 0.02% 352
2021
Q3
– Sell
-1,794
Closed -$323K – 928
2021
Q2
$323K Hold
1,794
– – ﹤0.01% 786
2021
Q1
$346K Buy
1,794
+531
+42% +$102K ﹤0.01% 603
2020
Q4
$255K Sell
1,263
-25
-2% -$5.17K ﹤0.01% 807
2020
Q3
$271K Buy
1,288
+267
+26% +$59.5K ﹤0.01% 617
2020
Q2
$224K Buy
+1,021
New +$204K ﹤0.01% 719
2020
Q1
– Sell
-2,247
Closed -$345K – 812
2019
Q4
$345K Sell
2,247
-99
-4% -$14.8K ﹤0.01% 739
2019
Q3
$356K Buy
+2,346
New +$371K ﹤0.01% 678
2018
Q3
– Sell
-6,120
Closed -$828K – 974
2018
Q2
$828K Buy
+6,120
New +$755K 0.01% 378
2016
Q1
– Sell
-4,899
Closed -$621K – 673
2015
Q4
$621K Buy
4,899
+61
+1% +$7.57K 0.01% 255
2015
Q3
$559K Buy
+4,838
New +$543K 0.01% 258

Other funds holding CLX

ALPS Advisors's CLX Position: Q1 2024 in Review

ALPS Advisors sold out of Clorox (CLX) in Q1 2024, closing a stake of 2,064 shares — an estimated $294K sold.

ALPS Advisors first reported a position in CLX in Q3 2015 and held it in 15 quarters. The position peaked at $1.67M in Q2 2022. 1,144 funds tracked by Wall St. Rank hold CLX as of Q1 2024.

  • ALPS Advisors reported no remaining Clorox position as of Q1 2024 after selling out during the quarter.
  • ALPS Advisors sold 2,064 Clorox shares in Q1 2024, an estimated $294K.
  • ALPS Advisors first reported a position in Clorox in Q3 2015 and held it in 15 quarters.
  • ALPS Advisors's Clorox position peaked at $1.67M in Q2 2022.
  • 1,144 funds tracked by Wall St. Rank held Clorox as of Q1 2024.

Based on ALPS Advisors's 13F filing for Q1 2024, filed 14 May 2024.